Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks.

The study found that adding a gp100 peptide vaccine to ipilimumab (a CTLA-4 inhibitor) did not improve its efficacy and instead showed a trend toward reduced response compared to ipilimumab alone 39 .

also in 53,322 other papers